Aevi Genomic Medicine, LLC – Material Contracts Watch

EX-10.2

from 8-K 3 pages Option Termination Agreement

12/34/56

EX-10.1

from 8-K 3 pages Option Termination Agreement

12/34/56

EX-10.5

from 425 17 pages Backstop Agreement

12/34/56

EX-10.4

from 425 5 pages Promissory Note

12/34/56

EX-10.3

from 8-K 5 pages Promissory Note

12/34/56

EX-10.3

from 425 5 pages Promissory Note

12/34/56

EX-10.3

from 425 5 pages Promissory Note

12/34/56

EX-10.2

from 8-K 5 pages Promissory Note

12/34/56

EX-10.2

from 425 16 pages Voting Agreement

12/34/56

EX-10.2

from 425 5 pages Promissory Note

12/34/56

EX-10.1

from 8-K 17 pages Voting Agreement

12/34/56

EX-10.1

from 425 16 pages Form of Contingent Value Rights Agreement

12/34/56

EX-10.1

from 425 17 pages Voting Agreement

12/34/56

EX-10.2

from 10-Q 2 pages November 11, 2019 1. You Sign This Memo in the Space Provided Below and Return It to Me No Later Than Wednesday, November 13, 2019

12/34/56

EX-10.1

from 10-Q 58 pages Option and License Agreement by and Between Medimmune Limited and Aevi Genomic Medicine, Inc

12/34/56

EX-10.4

from 10-Q 3 pages Amendment No. 4 to Sponsored Research Agreement

12/34/56

EX-10.3

from 10-Q 3 pages Amendment No. 3 to License Agreement

12/34/56

EX-10.2

from 10-Q 13 pages Royalty Agreement

12/34/56

EX-10.1

from 10-Q 109 pages Exclusive License Agreement by and Between Osi Pharmaceuticals, LLC and Aevi Genomic Medicine, Inc. July 15, 2019 Exclusive License Agreement

12/34/56

EX-10.1

from 8-K 2 pages Material contract

12/34/56